Skip to content

Novel Evaluation of Aspirated Follicular Fluid

Presence and Quantification of Inflammatory Cytokines, Dendritic Cells, Vasorin and Soluble Flt1 in Aspirated Follicular Fluid

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02999555
Enrollment
100
Registered
2016-12-21
Start date
2017-02-01
Completion date
2018-12-31
Last updated
2017-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovary Inflammation

Brief summary

A molecular study of follicular fluid aspirated from ovarian follicles during routine in vitro fertilization treatment, after the eggs were identified and separated.

Detailed description

Ovarian stimulation is a routine part of in vitro fertilization treatment: this process involves an inflammatory response in the developing follicles. We still do not completely understand the complex interactions leading to the maturation of the egg and the multiple interactions of the egg with its supporting cells. In this study we will assess follicular fluid, letf over after the eggs were identified and separated, for the presence of inflammatory mediators, dendritic cells , vasorin and soluble Flt1. The presence and quantification of these factors, as well as their correlation with the size of the aspirated follicle is the focus of this study.

Interventions

PROCEDUREOvum pickup

Ovum pickup or Egg retrieval, that is performed not for the purpose of the study, but for the purpose of well known in vitro fertilization indications

Sponsors

Weizmann Institute of Science
CollaboratorOTHER
Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* All women going through a fertility/ fertility preservation indicated egg retrieval in the in vitro fertilization (IVF) unit in 'Meir medical center', * Patients' informed consent

Exclusion criteria

* Patients refusing to take part in the study

Design outcomes

Primary

MeasureTime frame
Soluble Vasorin levels24 hours post egg retrieval
Soluble Flt 1 levels24 hours post egg retrieval
Dendritic cells quantification24 hours post egg retrieval

Countries

Israel

Contacts

Primary ContactAnat Hershko Klement, MD
anat.klement@gmail.com972549170084

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026